APA (7th ed.) Citation

LJ, W., M, D., G, M., M, Z., J, K., M, W., . . . H, S. (2023). Uncoupling of platelet granule release and integrin activation suggests GPIIb/IIIa as a therapeutic target in COVID-19. Blood advances, 7(11), 2324. https://doi.org/10.1182/bloodadvances.2022008666

Chicago Style (17th ed.) Citation

LJ, Weiss, et al. "Uncoupling of Platelet Granule Release and Integrin Activation Suggests GPIIb/IIIa as a Therapeutic Target in COVID-19." Blood Advances 7, no. 11 (2023): 2324. https://doi.org/10.1182/bloodadvances.2022008666.

MLA (9th ed.) Citation

LJ, Weiss, et al. "Uncoupling of Platelet Granule Release and Integrin Activation Suggests GPIIb/IIIa as a Therapeutic Target in COVID-19." Blood Advances, vol. 7, no. 11, 2023, p. 2324, https://doi.org/10.1182/bloodadvances.2022008666.